nodes	percent_of_prediction	percent_of_DWPC	metapath
Trilostane—HSD3B1—corpus luteum—hypothyroidism	0.212	0.326	CbGeAlD
Trilostane—HSD3B1—seminiferous tubule of testis—hypothyroidism	0.18	0.276	CbGeAlD
Trilostane—ESR2—seminiferous tubule of testis—hypothyroidism	0.0464	0.0715	CbGeAlD
Trilostane—HSD3B1—Glucocorticoid biosynthesis—POMC—hypothyroidism	0.0365	0.111	CbGpPWpGaD
Trilostane—HSD3B1—Androgen biosynthesis—POMC—hypothyroidism	0.0283	0.086	CbGpPWpGaD
Trilostane—HSD3B2—Glucocorticoid biosynthesis—POMC—hypothyroidism	0.0276	0.0841	CbGpPWpGaD
Trilostane—HSD3B2—Androgen biosynthesis—POMC—hypothyroidism	0.0214	0.0652	CbGpPWpGaD
Trilostane—ESR2—Nuclear Receptors—THRA—hypothyroidism	0.0211	0.0643	CbGpPWpGaD
Trilostane—HSD3B1—adrenal cortex—hypothyroidism	0.0184	0.0283	CbGeAlD
Trilostane—ESR2—Nuclear Receptor transcription pathway—THRA—hypothyroidism	0.0167	0.0508	CbGpPWpGaD
Trilostane—HSD3B1—gonad—hypothyroidism	0.0152	0.0234	CbGeAlD
Trilostane—HSD3B2—adrenal cortex—hypothyroidism	0.0146	0.0224	CbGeAlD
Trilostane—ESR2—Nuclear Receptors—THRB—hypothyroidism	0.0136	0.0414	CbGpPWpGaD
Trilostane—HSD3B1—adrenal gland—hypothyroidism	0.0133	0.0204	CbGeAlD
Trilostane—HSD3B1—female gonad—hypothyroidism	0.0124	0.019	CbGeAlD
Trilostane—HSD3B2—gonad—hypothyroidism	0.0121	0.0185	CbGeAlD
Trilostane—HSD3B2—pituitary gland—hypothyroidism	0.0118	0.0181	CbGeAlD
Trilostane—HSD3B1—Metabolism of steroid hormones and vitamin D—POMC—hypothyroidism	0.0117	0.0357	CbGpPWpGaD
Trilostane—HSD3B1—testis—hypothyroidism	0.011	0.0169	CbGeAlD
Trilostane—ESR2—Nuclear Receptor transcription pathway—THRB—hypothyroidism	0.0108	0.0327	CbGpPWpGaD
Trilostane—ESR1—Nuclear Receptors—THRA—hypothyroidism	0.0107	0.0324	CbGpPWpGaD
Trilostane—HSD3B2—adrenal gland—hypothyroidism	0.0105	0.0162	CbGeAlD
Trilostane—HSD3B1—cerebellum—hypothyroidism	0.0101	0.0156	CbGeAlD
Trilostane—HSD3B2—female gonad—hypothyroidism	0.0098	0.0151	CbGeAlD
Trilostane—HSD3B2—Metabolism of steroid hormones and vitamin D—POMC—hypothyroidism	0.00889	0.0271	CbGpPWpGaD
Trilostane—HSD3B2—testis—hypothyroidism	0.00869	0.0134	CbGeAlD
Trilostane—ESR1—Nuclear Receptor transcription pathway—THRA—hypothyroidism	0.00842	0.0256	CbGpPWpGaD
Trilostane—Drostanolone—SHBG—hypothyroidism	0.00747	0.348	CrCbGaD
Trilostane—ESR1—Nuclear Receptors—THRB—hypothyroidism	0.00687	0.0209	CbGpPWpGaD
Trilostane—ESR2—SIDS Susceptibility Pathways—DLX2—hypothyroidism	0.00683	0.0208	CbGpPWpGaD
Trilostane—ESR1—Nuclear Receptor transcription pathway—THRB—hypothyroidism	0.00543	0.0165	CbGpPWpGaD
Trilostane—HSD3B1—Corticotropin-releasing hormone—POMC—hypothyroidism	0.00517	0.0157	CbGpPWpGaD
Trilostane—ESR2—heart—hypothyroidism	0.00459	0.00707	CbGeAlD
Trilostane—ESR2—Generic Transcription Pathway—ZNF764—hypothyroidism	0.00448	0.0136	CbGpPWpGaD
Trilostane—ESR2—SIDS Susceptibility Pathways—THRB—hypothyroidism	0.0044	0.0134	CbGpPWpGaD
Trilostane—ESR2—cardiovascular system—hypothyroidism	0.00433	0.00667	CbGeAlD
Trilostane—ESR1—Regulation of nuclear SMAD2/3 signaling—NKX2-5—hypothyroidism	0.00414	0.0126	CbGpPWpGaD
Trilostane—Danazol—SHBG—hypothyroidism	0.00403	0.188	CrCbGaD
Trilostane—ESR2—Validated nuclear estrogen receptor alpha network—PRL—hypothyroidism	0.00401	0.0122	CbGpPWpGaD
Trilostane—ESR2—gonad—hypothyroidism	0.00393	0.00605	CbGeAlD
Trilostane—HSD3B2—Corticotropin-releasing hormone—POMC—hypothyroidism	0.00392	0.0119	CbGpPWpGaD
Trilostane—ESR2—pituitary gland—hypothyroidism	0.00384	0.0059	CbGeAlD
Trilostane—HSD3B1—Metabolism—IYD—hypothyroidism	0.00369	0.0112	CbGpPWpGaD
Trilostane—ESR2—adrenal gland—hypothyroidism	0.00343	0.00527	CbGeAlD
Trilostane—ESR2—blood—hypothyroidism	0.00343	0.00527	CbGeAlD
Trilostane—Methyltestosterone—SHBG—hypothyroidism	0.00341	0.159	CrCbGaD
Trilostane—ESR2—thyroid gland—hypothyroidism	0.00331	0.00509	CbGeAlD
Trilostane—ESR2—Plasma membrane estrogen receptor signaling—IGF1—hypothyroidism	0.00326	0.00992	CbGpPWpGaD
Trilostane—ESR2—female gonad—hypothyroidism	0.0032	0.00492	CbGeAlD
Trilostane—ESR1—heart—hypothyroidism	0.00315	0.00484	CbGeAlD
Trilostane—HSD3B1—Metabolism—ATP5O—hypothyroidism	0.00314	0.00956	CbGpPWpGaD
Trilostane—ESR1—Nuclear signaling by ERBB4—PRL—hypothyroidism	0.003	0.00914	CbGpPWpGaD
Trilostane—ESR1—cardiovascular system—hypothyroidism	0.00297	0.00457	CbGeAlD
Trilostane—HSD3B1—Metabolism—TPO—hypothyroidism	0.00295	0.00899	CbGpPWpGaD
Trilostane—ESR2—Generic Transcription Pathway—THRA—hypothyroidism	0.00288	0.00878	CbGpPWpGaD
Trilostane—ESR2—testis—hypothyroidism	0.00284	0.00436	CbGeAlD
Trilostane—HSD3B2—Metabolism—IYD—hypothyroidism	0.0028	0.00852	CbGpPWpGaD
Trilostane—HSD3B1—Metabolism of lipids and lipoproteins—PIK3C2A—hypothyroidism	0.00274	0.00833	CbGpPWpGaD
Trilostane—ESR1—gonad—hypothyroidism	0.00269	0.00415	CbGeAlD
Trilostane—ESR2—liver—hypothyroidism	0.00268	0.00412	CbGeAlD
Trilostane—ESR1—pituitary gland—hypothyroidism	0.00263	0.00404	CbGeAlD
Trilostane—ESR2—cerebellum—hypothyroidism	0.00262	0.00403	CbGeAlD
Trilostane—Estradiol—SHBG—hypothyroidism	0.00246	0.115	CrCbGaD
Trilostane—HSD3B2—Metabolism—ATP5O—hypothyroidism	0.00238	0.00725	CbGpPWpGaD
Trilostane—ESR1—adrenal gland—hypothyroidism	0.00235	0.00361	CbGeAlD
Trilostane—ESR1—blood—hypothyroidism	0.00235	0.00361	CbGeAlD
Trilostane—ESR1—thyroid gland—hypothyroidism	0.00227	0.00349	CbGeAlD
Trilostane—ESR1—Generic Transcription Pathway—ZNF764—hypothyroidism	0.00226	0.00687	CbGpPWpGaD
Trilostane—HSD3B2—Metabolism—TPO—hypothyroidism	0.00224	0.00681	CbGpPWpGaD
Trilostane—ESR1—female gonad—hypothyroidism	0.00219	0.00337	CbGeAlD
Trilostane—ESR2—Gene Expression—ZNF764—hypothyroidism	0.00215	0.00656	CbGpPWpGaD
Trilostane—Progesterone—SHBG—hypothyroidism	0.00209	0.0975	CrCbGaD
Trilostane—HSD3B2—Metabolism of lipids and lipoproteins—PIK3C2A—hypothyroidism	0.00207	0.00631	CbGpPWpGaD
Trilostane—ESR2—Generic Transcription Pathway—NKX2-5—hypothyroidism	0.00205	0.00625	CbGpPWpGaD
Trilostane—ESR1—Validated nuclear estrogen receptor alpha network—PRL—hypothyroidism	0.00202	0.00615	CbGpPWpGaD
Trilostane—Testosterone—SHBG—hypothyroidism	0.00198	0.0922	CrCbGaD
Trilostane—ESR1—testis—hypothyroidism	0.00194	0.00299	CbGeAlD
Trilostane—ESR2—Generic Transcription Pathway—THRB—hypothyroidism	0.00186	0.00566	CbGpPWpGaD
Trilostane—ESR1—liver—hypothyroidism	0.00184	0.00282	CbGeAlD
Trilostane—ESR1—cerebellum—hypothyroidism	0.00179	0.00276	CbGeAlD
Trilostane—ESR2—SIDS Susceptibility Pathways—AVP—hypothyroidism	0.00175	0.00533	CbGpPWpGaD
Trilostane—ESR1—Plasma membrane estrogen receptor signaling—IGF1—hypothyroidism	0.00164	0.005	CbGpPWpGaD
Trilostane—ESR1—Generic Transcription Pathway—THRA—hypothyroidism	0.00145	0.00443	CbGpPWpGaD
Trilostane—ESR2—Gene Expression—THRA—hypothyroidism	0.00139	0.00423	CbGpPWpGaD
Trilostane—HSD3B1—Metabolism—TSHB—hypothyroidism	0.00137	0.00416	CbGpPWpGaD
Trilostane—HSD3B1—Metabolism—PIK3C2A—hypothyroidism	0.00122	0.00371	CbGpPWpGaD
Trilostane—HSD3B1—Metabolism of lipids and lipoproteins—POMC—hypothyroidism	0.0012	0.00366	CbGpPWpGaD
Trilostane—ESR1—Gene Expression—ZNF764—hypothyroidism	0.00109	0.00331	CbGpPWpGaD
Trilostane—HSD3B2—Metabolism—TSHB—hypothyroidism	0.00104	0.00315	CbGpPWpGaD
Trilostane—ESR1—Generic Transcription Pathway—NKX2-5—hypothyroidism	0.00104	0.00315	CbGpPWpGaD
Trilostane—HSD3B1—Metabolism—SLC5A5—hypothyroidism	0.00102	0.00312	CbGpPWpGaD
Trilostane—ESR1—Signaling by ERBB4—PRL—hypothyroidism	0.00101	0.00308	CbGpPWpGaD
Trilostane—ESR2—Gene Expression—NKX2-5—hypothyroidism	0.000989	0.00301	CbGpPWpGaD
Trilostane—ESR2—Integrated Pancreatic Cancer Pathway—IGF1—hypothyroidism	0.000952	0.0029	CbGpPWpGaD
Trilostane—ESR1—Generic Transcription Pathway—THRB—hypothyroidism	0.000937	0.00285	CbGpPWpGaD
Trilostane—HSD3B2—Metabolism—PIK3C2A—hypothyroidism	0.000924	0.00281	CbGpPWpGaD
Trilostane—HSD3B2—Metabolism of lipids and lipoproteins—POMC—hypothyroidism	0.000911	0.00277	CbGpPWpGaD
Trilostane—ESR2—Gene Expression—THRB—hypothyroidism	0.000895	0.00272	CbGpPWpGaD
Trilostane—HSD3B2—Metabolism—SLC5A5—hypothyroidism	0.000776	0.00236	CbGpPWpGaD
Trilostane—ESR1—Gene Expression—THRA—hypothyroidism	0.0007	0.00213	CbGpPWpGaD
Trilostane—HSD3B1—Metabolism—POMC—hypothyroidism	0.000536	0.00163	CbGpPWpGaD
Trilostane—ESR1—Gene Expression—NKX2-5—hypothyroidism	0.000499	0.00152	CbGpPWpGaD
Trilostane—ESR1—Integrated Pancreatic Cancer Pathway—IGF1—hypothyroidism	0.00048	0.00146	CbGpPWpGaD
Trilostane—ESR1—Gene Expression—THRB—hypothyroidism	0.000451	0.00137	CbGpPWpGaD
Trilostane—HSD3B2—Metabolism—POMC—hypothyroidism	0.000406	0.00124	CbGpPWpGaD
Trilostane—ESR1—Signaling Pathways—CLTC—hypothyroidism	0.000257	0.000783	CbGpPWpGaD
Trilostane—ESR1—Signaling Pathways—TRH—hypothyroidism	0.000222	0.000677	CbGpPWpGaD
Trilostane—ESR1—Signaling Pathways—TSHB—hypothyroidism	0.000198	0.000603	CbGpPWpGaD
Trilostane—ESR1—Signaling Pathways—TSHR—hypothyroidism	0.000198	0.000603	CbGpPWpGaD
Trilostane—ESR1—Signaling Pathways—SH2B3—hypothyroidism	0.000177	0.000537	CbGpPWpGaD
Trilostane—ESR1—Signaling Pathways—PRL—hypothyroidism	0.000131	0.000399	CbGpPWpGaD
Trilostane—ESR1—Signaling Pathways—VAV3—hypothyroidism	0.000121	0.000369	CbGpPWpGaD
Trilostane—ESR1—Signaling Pathways—AVP—hypothyroidism	0.000117	0.000355	CbGpPWpGaD
Trilostane—ESR1—Signaling Pathways—POMC—hypothyroidism	7.76e-05	0.000236	CbGpPWpGaD
Trilostane—ESR1—Signaling Pathways—IGF1—hypothyroidism	7.46e-05	0.000227	CbGpPWpGaD
